Cargando…
Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis
Mitohormesis is an adaptive response induced by a mild mitochondrial stress that promotes longevity and metabolic health in different organisms. This mechanism has been proposed as the cause of the increase in the survival in Coq7(+/−) (Mclk1(+/−)) mice, which show hepatic reduction of COQ7, early m...
Autores principales: | Rodríguez-Hidalgo, María, Luna-Sánchez, Marta, Hidalgo-Gutiérrez, Agustín, Barriocanal-Casado, Eliana, Mascaraque, Cristina, Acuña-Castroviejo, Darío, Rivera, Margarita, Escames, Germaine, López, Luis C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143522/ https://www.ncbi.nlm.nih.gov/pubmed/30228311 http://dx.doi.org/10.1038/s41598-018-32190-y |
Ejemplares similares
-
β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9
(R239X) mice
por: Hidalgo‐Gutiérrez, Agustín, et al.
Publicado: (2018) -
CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome
por: Luna‐Sánchez, Marta, et al.
Publicado: (2016) -
β-RA Targets Mitochondrial Metabolism and Adipogenesis, Leading to Therapeutic Benefits against CoQ Deficiency and Age-Related Overweight
por: Hidalgo-Gutiérrez, Agustín, et al.
Publicado: (2021) -
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease
por: Barriocanal-Casado, Eliana, et al.
Publicado: (2019) -
The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency
por: González-García, Pilar, et al.
Publicado: (2022)